financetom
Business
financetom
/
Business
/
ArcelorMittal's Q1 Adjusted Earnings, Revenue Fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ArcelorMittal's Q1 Adjusted Earnings, Revenue Fall
May 2, 2024 1:27 AM

04:11 AM EDT, 05/02/2024 (MT Newswires) -- ArcelorMittal ( MT ) reported Q1 adjusted earnings Thursday of $1.16 per basic share, down from $1.28 a year earlier.

Three analysts polled by Capital IQ expected $0.88.

Revenue for the quarter ended March 31 was $16.28 billion, compared with $18.5 billion a year ago.

Analysts surveyed by Capital IQ expected $16.26 billion.

The company said it expects full-year 2024 capital expenditures of $4.5 billion to $5 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Signet Jewelers Shares Slump After Cutting Fiscal Q4 Sales Guidance
Update: Signet Jewelers Shares Slump After Cutting Fiscal Q4 Sales Guidance
Jan 14, 2025
12:00 PM EST, 01/14/2025 (MT Newswires) -- (Updates with stock move in the headline and first paragraph.) Signet Jewelers ( SIG ) shares were down more than 26% in recent Tuesday trading after the company slashed its fiscal Q4 sales outlook. The company said it now expects sales of $2.32 billion to $2.34 billion for the quarter, lower than its...
Major US Pharmacy Benefit Managers Inflated Drug Prices for Over $7.3 Billion Gain, FTC Says
Major US Pharmacy Benefit Managers Inflated Drug Prices for Over $7.3 Billion Gain, FTC Says
Jan 14, 2025
11:59 AM EST, 01/14/2025 (MT Newswires) -- UnitedHealth Group's ( UNH ) OptumRx, CVS Health's ( CVS ) Caremark Rx and Cigna's ( CI ) Express Scripts marked up a number of specialty generic drugs at their affiliated pharmacies by hundreds or thousands of percent, the US Federal Trade Commission said Tuesday. The practice allowed the three pharmacy benefit managers...
IBM's Q4 Results Set to Be In-line Amid Demand, Foreign Exchange Challenges, UBS Says
IBM's Q4 Results Set to Be In-line Amid Demand, Foreign Exchange Challenges, UBS Says
Jan 14, 2025
12:00 PM EST, 01/14/2025 (MT Newswires) -- International Business Machines ( IBM ) is expected to report fourth-quarter results in line with estimates, but demand challenges and foreign exchange impacts could cause some turbulence, UBS said in a note Monday. Analysts, including David Vog, said that a slower-than-expected recovery in IT demand and a tough comparison from a $241 million...
--KKR Faces DOJ Lawsuit for Allegedly Disregarding Premerger Antitrust Review Process
--KKR Faces DOJ Lawsuit for Allegedly Disregarding Premerger Antitrust Review Process
Jan 14, 2025
11:56 AM EST, 01/14/2025 (MT Newswires) -- Price: 143.04, Change: +1.79, Percent Change: +1.26 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved